Quick Takeaways
- Panacea Innovation Ltd filed SCHEDULE 13D/A for Atara Biotherapeutics, Inc. Common Stock (ATRA).
- Disclosed ownership: 20%.
- Date of event: 12 Jan 2026.
Quoteable Key Fact
"Panacea Innovation Ltd disclosed 20% ownership in Atara Biotherapeutics, Inc. Common Stock (ATRA) on 12 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Innovation Limited | 20% | 1,632,345 | 0 | 1,632,345 | /s/ James Huang | James Huang, Founding Managing Partner | 0002010692 |
| Panacea Venture Healthcare Fund II, L.P. | 18% | 1,324,446 | 0 | 1,324,446 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner By: Panacea Innovation Limited, its sole owner By: /s/ James Huang | James Huang, Founding Managing Partner | 0001869939 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 18% | 1,324,446 | 0 | 1,324,446 | By: Panacea Innovation Limited, its sole owner By: /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Opportunity Fund I, L.P. | 4.1% | 307,899 | 0 | 307,899 | By: Panacea Opportunity Fund I GP Company, Ltd., its general partner By: Panacea Innovation Limited, its sole owner By: /s/ James Huang | James Huang, Founding Managing Partner | 0001869966 |
| Panacea Opportunity Fund I GP Company, Ltd. | 4.1% | 307,899 | 0 | 307,899 | By: Panacea Innovation Limited, its sole owner By: /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 20% | 1,632,345 | 0 | 1,632,345 | /s/ James Huang | James Huang | 0001573160 |